Re: Annual Financial Reporting

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10510 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Annual Financial Reporting

in response to

Annual Financial Reporting

KOO-KOO2

posted on Mar 22, 2024 03:10PM

"Zenith's 3rd quarter filings (January 31, 2024) are overdue"

I note that Zenith reported the January 31, 2023, (a year ago) interim financial statement on April 6, 2023.